vasilios shorts will not rise to >10% unless Ryoncil sales fail to grow substantially after June 30. They will not go to 20% as there is the possibility of a partnership deal. They have grown to 5% as they are simply betting that Ryoncil will take longer to sell than company commentary around the 19th December FDA announcement. They also know the sensitivity of Mesoblasts share price to Ryoncil sales. Hedge funds are paid high performance fees and that motivates them to collect whatever data they can get. They would have industry contacts as otherwise they would not have shorted Mesoblast in the first place.
MSB Price at posting:
$1.73 Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)